Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-02-25 @ 8:19 PM
Study NCT ID:
NCT03787758
Status:
COMPLETED
Last Update Posted:
2025-09-17
First Post:
2018-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B
Sponsor:
Supernus Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-17
First Submit QC Date:
None
Study First Post Date:
2018-12-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-17
Last Update Post Date Type:
ESTIMATED